Rockefeller Capital Management L.P.

Position in CRDF — Cardiff Oncology, Inc.

CIK 1739439 NEW YORK, NY

Position in CRDF

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$91,530

-$67,235 QoQ

Shares Held

56,500

0.0% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Rockefeller Capital Management L.P. holds $285,796,172 across 243 Biotechnology names. CRDF ranks #75 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,655	$66,826,941
2	JAZZ	Jazz Pharmaceuticals plc	249,174	$47,106,343
3	PTCT	Ptc Therapeutics, Inc.	384,672	$26,207,702
4	ACAD	Acadia Pharmaceuticals Inc	1,027,357	$22,868,965
5	REGN	Regeneron Pharmaceuticals, Inc.	28,520	$22,035,691
6	BMRN	Biomarin Pharmaceutical Inc	372,197	$21,025,406
7	MDGL	Madrigal Pharmaceuticals, Inc.	33,849	$17,718,934
8	CORT	Corcept Therapeutics Inc	123,497	$4,978,162

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$91,530	56,500	0.0%	Shares	Defined	2026-05-14
2025-12-31	$158,765	56,500	-9.6%	Shares	Defined	2026-03-17
2025-09-30	$128,750	62,500	+38243.6%	Shares	Defined	2025-11-14
2022-09-30	$251	163	0.0%	Shares	Defined	2022-11-02
2022-06-30	$358	163	+2228.6%	Shares	Defined	2022-08-12
2022-03-31	$17	7	+16.7%	Shares	Defined	2022-05-13
2021-12-31	$36	6	-99.3%	Shares	Defined	2022-02-14
2021-06-30	$5,865	882	-28.6%	Shares	Defined	2021-08-10
2021-03-31	$11,436	1,235	+609.8%	Shares	Defined	2021-05-11
2020-12-31	$3,130	174	-97.5%	Shares	Defined	2021-02-12
2020-09-30	$100,096	7,054	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.